Risk Factors Associated with Death in In-Hospital Pediatric Convulsive Status Epilepticus by Loddenkemper, Tobias et al.
 
Risk Factors Associated with Death in In-Hospital Pediatric
Convulsive Status Epilepticus
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Loddenkemper, Tobias, Tanvir U. Syed, Sriram Ramgopal,
Deepak Gulati, Sikawat Thanaviratananich, Sanjeev V. Kothare,
Amer Alshekhlee, and Mohamad Z. Koubeissi. 2012. Risk factors
associated with death in in-hospital pediatric convulsive status
epilepticus. PLoS ONE 7(10): e47474.
Published Version doi:10.1371/journal.pone.0047474
Accessed February 19, 2015 11:51:03 AM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:10510852
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAARisk Factors Associated with Death in In-Hospital
Pediatric Convulsive Status Epilepticus
Tobias Loddenkemper
1., Tanvir U. Syed
2., Sriram Ramgopal
1*, Deepak Gulati
2,
Sikawat Thanaviratananich
2, Sanjeev V. Kothare
1, Amer Alshekhlee
3, Mohamad Z. Koubeissi
2,4
1Department of Neurology, Children’s Hospital Boston and Harvard Medical School, Boston, Massachusetts, United States of America, 2Department of Neurology, Case
Western Reserve University and University Hospitals, Cleveland, Ohio, United States of America, 3Department of Neurology, St Louis University, St. Louis, Missouri, United
States of America, 4Department of Neurology, George Washington University, Washington, D.C., United States of America
Abstract
Objective: To evaluate in-patient mortality and predictors of death associated with convulsive status epilepticus (SE) in a
large, multi-center, pediatric cohort.
Patients and Methods: We identified our cohort from the KID Inpatient Database for the years 1997, 2000, 2003 and 2006.
We queried the database for convulsive SE, associated diagnoses, and for inpatient death. Univariate logistic testing was
used to screen for potential risk factors. These risk factors were then entered into a stepwise backwards conditional
multivariable logistic regression procedure. P-values less than 0.05 were taken as significant.
Results: We identified 12,365 (5,541 female) patients with convulsive SE aged 0–20 years (mean age 6.2 years, standard
deviation 5.5 years, median 5 years) among 14,965,571 pediatric inpatients (0.08%). Of these, 117 died while in the hospital
(0.9%). The most frequent additional admission ICD-9 code diagnoses in addition to SE were cerebral palsy, pneumonia, and
respiratory failure. Independent risk factors for death in patients with SE, assessed by multivariate calculation, included near
drowning (Odds ratio [OR] 43.2; Confidence Interval [CI] 4.4–426.8), hemorrhagic shock (OR 17.83; CI 6.5–49.1), sepsis (OR
10.14; CI 4.0–25.6), massive aspiration (OR 9.1; CI 1.8–47), mechanical ventilation .96 hours (OR9; 5.6–14.6), transfusion (OR
8.25; CI 4.3–15.8), structural brain lesion (OR7.0; CI 3.1–16), hypoglycemia (OR5.8; CI 1.75–19.2), sepsis with liver failure (OR
14.4; CI 5–41.9), and admission in December (OR3.4; CI 1.6–4.1). African American ethnicity (OR 0.4; CI 0.2–0.8) was
associated with a decreased risk of death in SE.
Conclusion: Pediatric convulsive SE occurs in up to 0.08% of pediatric inpatient admissions with a mortality of up to 1%.
There appear to be several risk factors that can predict mortality. These may warrant additional monitoring and aggressive
management.
Citation: Loddenkemper T, Syed TU, Ramgopal S, Gulati D, Thanaviratananich S, et al. (2012) Risk Factors Associated with Death in In-Hospital Pediatric
Convulsive Status Epilepticus. PLoS ONE 7(10): e47474. doi:10.1371/journal.pone.0047474
Editor: Joshua L. Bonkowsky, University of Utah School of Medicine, United States of America
Received June 14, 2012; Accepted September 12, 2012; Published October 26, 2012
Copyright:  2012 Loddenkemper et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: TL serves on the Laboratory Accreditation Board for Long Term (Epilepsy and ICU) Monitoring (ABRET), serves as an Associate Editor for Seizure, serves
on the American Board of Clinical Neurophysiology, and on the Council of the American Clinical Neurophysiology Society, performs Video EEG longterm
monitoring, EEGs, and other electrophysiological studies at Children’s Hospital Boston and bills for these procedures (20%), receives support from National
Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) 1R21NS076859-01 (2011-2013), is supported by a Career Development
Fellowship Award from Harvard Medical School and Children’s Hospital Boston, by the Program for Quality and Safety at Children’s Hospital Boston, from the
Payer Provider Quality Initiative, the Translational Research Project at Children’s Hospital Boston, receives funding from the Epilepsy Foundation of America (EF-
213583 & EF-213882), and from the Center for Integration of Medicine & Innovative Technology (CIMIT/DoD), and received investigator initiated research support
from Eisai and Lundbeck. Drs. TS, SR, DG, and ST have nothing to disclose. Dr. SK performs Video EEG longterm monitoring, EEGs, and other electrophysiological
studies at Children’s Hospital Boston and bills for these procedures, is interim medical director of the Center for Pediatric Sleep Disorders at Children’s Hospital
Boston, and has received research support from National Institute of Health (1 RC1 HL099749-01 (R21) (2009-12), and RFA-HL-09-001 (2010-14) and the Harvard
Catalyst (2010-11). He also serves on the editorial board of the journal Pediatric Neurology. Dr. AA has nothing to disclose. Dr. MK has no conflict of interest
related to the current work, has received grant support from the Coulter Foundation, and is on the Speakers’ Bureaus of UCB and Pfizer. The funders had nor o l ei n
study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: TL serves on the Laboratory Accreditation Board for Long Term (Epilepsy and ICU) Monitoring (ABRET), performs Video EEG longterm
monitoring, EEGs, and other electrophysiological studies at Children’s Hospital Boston and bills for these procedures (20%). He has received investigator initiated
research support from Eisai Inc. Dr. SK performs Video EEG longterm monitoring, EEGs, and other electrophysiological studies at Children’s Hospital Boston and
bills for these procedures. He also serves on the editorial board of the Journal of Pediatric Neurology. Dr. MK is on the Speakers’ Bureaus of UCB and Pfizer. There
are no patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data
and materials.
* E-mail: Sriram.ramgopal@childrens.harvard.edu
. These authors contributed equally to this work.
PLOS ONE | www.plosone.org 1 October 2012 | Volume 7 | Issue 10 | e47474Introduction
Status epilepticus (SE) is characterized by prolonged seizures or
by multiple seizures without full restoration of consciousness
between events [1]. The condition is associated with significant
morbidity and mortality. SE is thought to have a fatality rate of
approximately 2% [2,3]. Complications of SE are also significant
and include refractory epilepsy, neurologic deficits and repeated
episodes of SE [4].
While a number of studies have identified associations for poor
outcomes in SE [5,6], the use of publically available hospital
databases with large sample sizes may allow for better determi-
nation of morbidity and mortality risk factors for patients with this
condition. In this study, we investigate potential risk factors leading
to death in children presenting with generalized convulsive SE.
Patients and Methods
Study Population
This study utilized patient data acquired from the Kids’
Inpatient Database (KID). The KID dataset has been set up
through the Healthcare Cost and Utilization Project (HCUP) and
is the only all-payer inpatient care database for children in the
United States. Data from both insured and uninsured pediatric
patients, defined as individuals less than 20 years of age, are
collected. Data collected from KID include demographic infor-
mation, including patient age, gender, race, median income and
ZIP code, primary and secondary diagnoses, procedures, payment
information, and patient length of stay. KID also collects
information on factors including hospital size, teaching status,
type of hospital and hospital location. We used data from the years
1997, 2000, 2003 and 2006. The 1997 database includes data
from 2,521 hospitals in 22 states, the 2000 database includes data
from 2,784 hospitals in 27 states, the 2003 database includes data
from 3,438 hospitals in 36 states, and the 2006 database includes
data from 3,739 hospitals in 38 states. Twenty percent of normal
newborn births and 80% of the inpatient admissions from each
institution are included in the dataset as a systematic random
sample [7].
Standard Protocol Approvals
Prior to data analysis, the Institutional Review Boards of Case
Western Reserve University and University Hospitals, Cleveland,
OH, and Boston Children’s Hospital, Boston, MA, granted
exempt status to this study. Informed consent was not required.
This study was done in accordance with the HCUP user
agreement.
Data Acquisition
We queried KID for cases with a diagnostic code of generalized
convulsive status epilepticus via usage of the International
Statistical Classification of Diseases and Related Health Problems,
9
th revision (ICD-9) code 345.3. This code corresponds to ‘‘grand
mal status’’. No other ICD-9 codes were used. Data pertaining to
month of admission, admission source (from the emergency room,
at birth, from outside the hospital and from outside the facility),
sex, elective admission or not, age, length of stay, ethnicity, income
level (assessed as median income per ZIP code), hospital type
(general hospital, children’s hospital, or general hospital with a
children’s unit), hospital bed size, hospital location (rural versus
urban and geographic region), and teaching status of hospital were
collected. We also used ICD-9 codes to collect data pertaining to
patient comorbidities, interventions and complications (table 1).
Outcomes pertaining to mortality, which were listed separately in
the KID dataset, were collected for each patient.
Statistical Analysis
Univariate logistic testing was used to screen for significant risk
factors of death. Risk factors with an associated p-value less than
0.20 were entered into a stepwise backwards conditional
multivariable logistic regression procedure. The multivariable
model only retained risk factors with an associated p-value less
than 0.05. Two-way interaction terms were entered one at a time
into the resulting multivariable model and were retained if the
associated p-value was less than 0.05. Model validity was assessed
using the Hosmer and Lemeshow goodness-of-fit test with p-value
greater than 0.05 indicating adequate model fit of data. All
statistical analyses were performed in Stata 11.0 (Statacorp,
College Station, TX).
Results
Description of Patient Population and Mortality Rate
A total of 14,965,571 patients were included based on the KID
datasets from 1997, 2000, 2003 and 2006. Of these, 12,365
patients (0.083%) were diagnosed with convulsive SE, including
5,541 (44.8%) girls. Five patients (,0.0001%) were excluded from
the study due to insufficient data for the tested variables. Mean
patient age was 6.265.5 years (range ,1–20 years, median 5
years). One-hundred-and-seventeen patients (0.95%) with convul-
sive SE died during their inpatient admission. Additional
demographic data are provided in table 2.
Risk Factor Analysis
Logistic testing was done to identify potential risk factors for
death in convulsive status epilepticus, and those risk factors
associated with a p-value of 0.20 were entered into a multivariate
model. Factors with a p-value of less than 0.05 were taken as
significant following model verification. Univariate and multivar-
iate calculations are provided in tables 1, 3 and 4.
Risk Factors Based on Demographic Data
African American children were at a significantly lower risk of
mortality following an episode of convulsive SE (p=0.009).
Patients in other racial groups did not have an associated increase
or decrease in mortality. No association was found between patient
age and mortality risk. Household income, calculated as the
average income in a ZIP code region, was also not a significant risk
factor for death.
Risk Factors Based on Hospital Admission
Using univariate analysis, cases referred from outside hospitals
were associated with a higher rate of mortality, as were Children’s
Hospitals, Teaching Hospitals, and General Hospitals with a
Children’s Unit. These findings were not significant in multivariate
analysis. Patient length of stay, weekend versus weekday admis-
sion, hospital size and geographic region of hospital were not
associated with an increased risk of mortality. None of these factors
emerged as significant in multivariate analysis.
Risk Factors Based on Comorbidities
A number of patient comorbidities corresponded to a greater
mortality risk in convulsive SE. Sepsis (p,0.001), hypoglycemia
(p=0.004), near-drowning episode (p=0.001), hemorrhagic shock
(p,0.001), structural brain lesions (p,0.001), massive aspiration
(p=0.008), and postoperative sepsis with liver failure (p,0.001)
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Predictor ICD-9 Code Total N Predictor N OR
Lower
95% Upper 95% P
Metabolic
Hyponatremia 276.1 12360 238 3.31 1.52 7.18 0.002
Hypoxia 799.0, 770.8, 768, 348.1,
768.5, 768.6, 768.9
12360 293 12.35 8.01 19.04 ,.001
Drug overdose 966 12360 12 - - -
Hepatic encephalopathy 572.2 12360 ,1 0 --- -
Metabolic derangements 277, 348.31 12360 105 4.26 1.54 11.76 0.005
Severe malnutrition 260, 261, 262, 263 12360 60 3.65 0.88 15.14 0.074
Toxic 349.82, 323.7, 983, 984,
985, 988, 989
12360 19 - - - -
Hypoglycemia 250.8, 251.0, 251.1, 251.2,
300.19, 775.6
12360 67 8.77 3.46 22.23 ,.001
Drug withdrawal 292.0, 779.5 12360 ,1 0 --- -
Infectious
Sepsis 038, 771.8, 995.91 995.92,
771.81
12360 44 33.56 16.17 69.66 ,.001
Cerebral malaria 084.9 12365 ,1 0 --- -
Disseminated tuberculosis 018 - - - - - -
Acute viral encephalitis 049.9, 062, 064, 139.0,
323.0, 323.01
12360 34 10.37 3.12 34.40 ,0.001
Central nervous system infections V12.42 12365 ,1 0 --- -
Meningoencephalitis 323.0, 323.4 12360 ,1 0 --- -
Bacterial meningitis 320, 320.7, 320.8, 320.81,
320.82, 320.9
12360 ,1 0 --- -
Infectious encephalopathy 136.9, 323.5, 323.9, 348.3 12360 394 2.57 1.29 5.10 ,.007
Severe malaria 084, 084.9, 084.4, 084.5,
084.6, 084.7, 084.8
12330 - - - - -
Pneumonia 480, 480.8, 480.9, 481, 482,
482.8, 483, 485, 011.6
12360 51 6.69 2.05 21.78 0.002
Meningitis 013.0, 036.0, 320, 047.8,
047.9, 320.1, 321, 320.8, 322
12360 44 - - - -
Bacteremia 790.7, 771.83 12360 58 - - - -
Viral encephalitis 062, 063, 064, 139.0, 323.0,
049.9
12360 34 10.37 3.12 34.39 ,.001
RSV infection 079.6 12360 42 2.57 0.35 18.81 0.354
Postoperative sepsis and liver failure 998.59 12360 26 59.93 26.14 137.42 ,.001
Septic shock 785.52, 785.59 12360 46 57.93 30.35 110.59 ,.001
Hemodynamic
Congenital heart disease 746.9 12360 ,1 0 --- -
Hypotension 458, 458.0, 458.1, 458.2,
458.29, 458.8, 458.9
12360 146 15.96 9.28 27.47 ,.001
Intractable hypertension 401, 403, 403.0, 405, 405.0 12360 104 5.48 2.19 13.71 ,.001
Cardiac failure 428.9 12360 ,1 0 --- -
Hemorrhagic shock 785.59, 958.4 12360 29 50.93 22.67 114.39 ,.001
Post cardiac arrest 997.1 12360 ,1 0 --- -
Neurologic
Cerebral palsy 333.71, 343, 343.0, 343.1,
343.2, 343.3, 343.8, 343.9
12360 2132 0.64 0.37 1.12 0.118
Subdural Hematoma 432.1, 767.0 12360 21 11.19 2.58 48.59 ,0.001
Cerebrovascular accident 434.01, 434.11, 434.91 12360 36 37.07 17.32 82.07 ,.007
Brain trauma 850, 767.0, 850.9 854, 310.2 12360 14 - - - -
Acute cerebrovascular disease 436, 437, 437.1, 437.8,
437.9 438, 438.8, 438.9
12360 46 2.34 0.32 17.10 0.403
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as hypertension, subdural hemorrhage, viral encephalitis, and
infectious encephalopathy were significant risk factors in univar-
iate analysis, they did not emerge as significant factors following
multivariate calculations. Other comorbidities, including a previ-
ous diagnosis of epilepsy, antiepileptic medication withdrawal,
fever, esophageal tears, post-cardiac arrest status, brainstem
tumors, infantile spasms, other encephalitis, and hydrocephalus
were not associated with increased mortality.
Risk Factors Based on Procedures
The need for blood transfusion was associated with greater risk
of death (p,0.001). While intubation was not a risk factor for
death, mechanical ventilation for more than 96 hours was
associated with a higher mortality (p,0.001). Ventriculoperitoneal
shunt placement was not associated with higher mortality.
Discussion
Summary
This retrospective study utilized the KID dataset to identify a
number of risk factors for poor outcome in pediatric patients
diagnosed with convulsive status epilepticus. Higher risk was
associated with end-of-year hospital admissions, various patient-
related comorbidities, blood transfusion and prolonged mechan-
ical ventilation. African American ethnicity was associated with a
lower risk of mortality. A review of the literature is presented in
table 5.
Mortality rate
The mortality rates of convulsive SE in previous studies vary.
Some studies report a less than 2% mortality [2,3] whereas other
studies provide figures over 30% [8]. The mortality rate of
convulsive SE in our study was approximately 1%. This finding
corresponds to mortality rates from previous research. A state-
wide study based in California utilized a dataset including over
Table 1. Cont.
Predictor ICD-9 Code Total N Predictor N OR
Lower
95% Upper 95% P
Brain death 348.8 12360 119 9.19 4.54 18.61 ,.001
Brainstem tumor 191.7, 225.9 12360 ,1 0 --- -
Structural brain lesion 348.8 12360 119 9.19 4.54 18.61 ,.001
Intracranial hemorrhage 800.3, 800.8 12360 ,1 0 --- -
Brainstem herniation 348.4 12360 33 24.46 9.90 60.40 ,.001
Epilepsy 345 12360 376 0.84 0.26 2.65 0.763
Generalized Convulsive Epilepsy 345.1 12360 38 - - - -
Generalized Non-Convulsive Epilepsy 345.0 12360 19 - - - -
Infantile spasms 345.6 12360 ,1 0 --- -
Hydrocephalus 331 12360 832 0.62 0.25 1.51 0.291
Obstructive hydrocephalus 331.4 12360 472 0.89 0.33 2.42 0.821
Communicating hydrocephalus 331.3 12360 16 - - - -
Idiopathic hydrocephalus 331.5 12360 ,1 0 --- -
Congenital hydrocephalus 742.3 12360 349 0.30 0.04 2.12 0.224
CNS Malformation in fetus 655.0 12360 ,1 0 --- -
Tuberous sclerosis 759.5 12360 124 0.85 0.12 6.13 0.871
Rasmussen encephalitis 323.81 12360 ,1 0 --- -
Other
Non compliance V15.81 12360 ,1 0 --- -
Near drowning 994.1 12360 ,10 26.38 2.93 237.80 0.004
Congenital malformations V13.6, V13.69 12360 ,1 0 --- -
Massive aspiration 507, 770.1, 770.18, E879.4 12360 711 2.25 1.28 3.96 0.005
Esophageal tear 530.89 12360 ,1 0 --- -
Fever 780.6 12360 612 1.04 0.45 2.37 0.929
Interventions
Transfusion 99.01–99.09 12360 110 36.48 22.21 59.93 ,0.001
Ventriculoperitoneal shunt 2.31–2.39 12360 23 4.79 0.64 35.82 0.127
Intubation 96.04 12360 19 - - - -
Mechanical ventilation 96.71 12360 3351 12.64 7.87 20.30 ,0.001
Mechanical ventilation 96 hours 96.72 12360 426 22.74 15.53 33.30 ,0.001
ICD-9 – International Classification of Disease, 9th edition, RSV – respiratory syncytial virus.
doi:10.1371/journal.pone.0047474.t001
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hospital mortality rate of 1.9% [3]. A prospective study evaluating
intractable epilepsy in 613 children found a death rate of 1.6%
over 4 years [9]. Another prospective study found a mortality rate
of 2% in 47 pediatric patients with SE [10]. Studies with higher
mortality rates may have analyzed high-risk subgroups, such as SE
patients with pediatric intensive care unit (ICU) admissions [8] or
cases of refractory SE only [11]. Because prolonged seizures are
thought to be a risk factor for complications and death, studies that
maintained criteria of a minimum seizure length of 30 or more
minutes may have subsequently reported higher fatality rates
[12,13]. Investigators who studied mortality over months to years
of follow-up reported higher fatality rates [12]. Most studies of SE
do not specifically investigate pediatric patients. Because the
mortality of SE may rise with age [5,14], the inclusion of adult
patients can result in a higher case-fatality rate. However, the age-
specific incidence of epilepsy is highest in infancy and early
childhood and decreases progressively as children grow up [15].
Demographic data
Race. Children of African American ethnicity were found to
have lower mortality rates in convulsive SE compared to children
of other ethnic groups. In a retrospective study analyzing risk
factors for mortality in status epilepticus in Richmond, Virginia,
African American ethnicity was found to correlate with decreased
mortality risk in univariate, though not multivariate, analysis [14].
While they may have decreased risk of mortality compared to
other racial groups, African American children have also been
noted to present in SE disproportionately more frequently [3,16].
Because decreased mortality in status persisted in spite of
consideration of socioeconomic factors, a heritable resistance to
seizure-related mortality in this population cannot be ruled out.
Sex. The importance of gender in the risk assessment of SE is
debated. While some studies have identified that males are more
likely to present in status [17], other studies have found the
opposite [18]. Mortality outcomes in status epilepticus between
males and females are similarly conflicting [3,5,6]. While our study
found that more males presented in SE than females, we did not
find sex to be a significant risk factor in predicting mortality
outcomes.
Age. Some studies have found an association between SE
mortality and children of younger ages [19], whereas others have
noted that older patients have a higher risk of death during SE
[5,14]. SE is also noted to occur more frequently in younger
patients [5]. Age was not found to be a significant independent risk
factor for death in our study.
Hospital Data
Time of Year. We tested each month individually as a
predictor of mortality and subsequently tested statistically signif-
icant months in the multivariable mortality model to account for
potential seasonal variations in disease severity, as may occur with
infectious or epidemic disease processes. Hospital admissions for
convulsive SE during the month of December were associated with
an increased risk of mortality. More research will be needed to
verify these data and to identify possible causes. Seasonal
variations in infections such as bacterial meningitis [20] and viral
encephalitis [21] and other respiratory tract infections may have
played a role in this annual variation.
Teaching and Children’s Hospitals. The univariate anal-
ysis identified a significant association between deaths and
admission into Teaching Hospitals, Children’s Hospitals and
General Hospitals with a Children’s unit. In addition, referrals
from outside hospitals are also associated with significant
mortality. None of these factors emerged as significant in the
multivariate analysis. We believe that some these findings may be
related to referral bias, as more severe cases of SE are likely to be
referred to Children’s Hospitals and teaching institutions.
Comorbidities
Symptomatic epilepsy. Structural brain lesions, as demon-
strated by imaging or autopsy findings, emerged as a risk factor for
death in our study. This finding is in concordance with results
from previous studies suggesting higher mortality in convulsive SE
patients with structural lesions, such as brain tumors [6], cerebral
dysgenesis [12,22]_ENREF_13, neurodegenerative disease [6],
cerebral palsy [12] or other brain malformations [19]. Mortality
may be higher in patients with acute symptomatic SE and
neurological injury [23].
Pulmonary complications. Aspiration was a common
comorbid condition associated with death in pediatric patients
Table 2. Patient Population.
Total patient population 14,965,571
Cases of Convulsive SE (%) 12,365 (0.083%)
Number of Females with SE 5,541 (44.8%)
Mean Age (SD; range) 6.2 (5.5; 0–20)
Deaths in SE Cases 117 patients
Case Fatality Rate 0.95%
Patient Demographics patients percent
Caucasian 4,697 49.11%
African American 1,943 20.35%
Hispanic 2,044 21.37%
Asian or Pacific Islander 275 2.88%
Native American 71 0.74%
Other 531 5.55%
SE – Status epilepticus; SD – standard deviation.
doi:10.1371/journal.pone.0047474.t002
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Predictor Total N Predictor N OR Lower 95% Upper 95% P
January Admission 12360 957 1.00
February Admission 12360 983 1.95 0.67 5.74 0.22
March Admission 12360 992 2.13 0.74 6.16 0.16
April Admission 12360 878 1.97 0.66 5.90 0.23
May Admission 12360 963 1.59 0.52 4.89 0.42
June Admission 12360 934 1.85 0.62 5.54 0.27
July Admission 12360 935 1.44 0.45 4.54 0.54
August Admission 12360 899 2.14 0.73 6.28 0.17
September Admission 12360 883 1.08 0.31 3.75 0.90
October Admission 12360 999 1.73 0.58 5.18 0.33
November Admission 12360 963 0.99 0.29 3.44 0.99
December Admission 12360 1042 4.11 1.55 10.89 0.01
Admission Source 121999
Emergency room 7674 1.00 - - -
Birth 2197 1.53 0.94 2.48 0.084
Outside Hospital 2042 2.07 1.32 3.23 0.001
Outside Facility 286 2.46 0.98 6.21 0.055
Weekend Admission 12146 3389 1.36 0.93 2.00 0.114
Female 12360 5537 1.17 0.81 1.69 0.392
Elective Admission 11333 738 1.34 0.67 2.66 0.48
Age in years (if more than 1 year old) 12319 - 1.03 0.99 1.06 0.108
Age in Days (if less than 1 year old) 801 - 1.00 0.99 1.00 0.327
Length of Stay 12360 - 1.03 1.02 1.04 ,0.001
Race 12360
White 4697 1.00
Black 1943 0.49 0.24 1.01 0.053
Hispanic 2044 0.78 0.43 1.41 0.412
Other 3676 1.43 0.95 2.15 0.088
Urban/Rural by ZIP Code 7506
Large 4306 1.00
Small 2187 1.27 0.76 2.10 0.361
Metropolitan 638 1.21 0.54 2.73 0.639
Non-core 375 1.18 0.42 3.32 0.754
Income per ZIP Code 12006
1
st quartile 3076 1.00
2
nd quartile 3133 1.11 0.64 1.92 0.722
3
rd quartile 2776 1.53 0.90 2.59 0.115
4
th quartile 3012 1.28 0.74 2.19 0.376
Hospital Type 11693
General 4897 1.00
General with children’s unit 4125 1.60 1.01 2.54 0.045
Children’s 2671 2.14 1.32 3.44 0.002
Hospital Bed Size 11936
Small 1696 1.00
Medium 3430 1.20 0.64 2.25 0.563
Large 6810 1.16 0.65 2.07 0.62
Urban Hospital 11936 11265 3.33 0.82 13.51 0.092
Hospital Region 12360
Northeast 2528 1.00
Risk Factors for Death in Status Epilepticus
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be an independent risk factor for mortality in our study.
Pneumonia was identified as a cause of death in a prior
retrospective pediatric study [22], a pediatric prospective study
[24], and in a pediatric drug trial for management of status
epilepticus [25]. In our population it is unclear how many cases of
pneumonia were causes or consequences of SE.
Sepsis and hemodynamic compromise. Sepsis emerged as
an important risk factor for death in our pediatric population.
Sepsis may occur as a consequence of pneumonia or from other
infective foci. A retrospective study on pediatric ICU patients
identified sepsis to be a major cause of death in children with
prolonged (.45 minute) episodes of SE [8]. Another study on
emergency management procedures in children presenting with
SE also identified sepsis as a risk factor for death [26].
Infections may also be an important cause of SE, particularly in
cases that were presumably induced by febrile illness or
pneumonia [27]. Our study also identified postoperative sepsis
with liver failure to be significant enough to constitute an
independent risk factor, and this finding is also backed by a
previous pediatric case series [28] and by another series on
refractory pediatric SE [4]. Hemorrhagic shock was identified as a
risk factor for death. In a trial comparing the use of phenytoin and
midazolam in school-age children, hemorrhagic shock was noted
as a cause of death [25].
Metabolic complications. Hypoglycemia emerged as an
independent risk factor for death in pediatric convulsive SE.
Hypoglycemia increased the risk of neurological sequelae in a
prospective study in children [29]. Hypoglycemia may also be a
cause of SE [10,16]. Metabolic complications were associated with
an increased risk of mortality using univariate analysis. Previous
work has noted similar findings [25] and has more specifically
associated deaths to hyponatremia [26]. Liver dysfunction, as
mentioned above, is another potential source of metabolic
dysfunction.
Near drowning. Convulsive SE related to near-drowning
episodes constituted an independent risk factor for mortality in our
series and other studies [30]. Near-drowning episodes may occur
as a consequence of seizures [31]. Conversely, SE may also occur
as a result of cerebral anoxia following such an event [32].
Intracranial infections. The importance of brain infections
in leading to SE or resulting in mortality has been noted in
previous studies. A prospective pediatric study identified menin-
gitis and encephalitis as causes of SE. Meningitis was also an
Table 3. Cont.
Predictor Total N Predictor N OR Lower 95% Upper 95% P
Midwest 2488 1.39 0.77 2.53 0.273
South 4125 1.13 0.65 1.98 0.669
West 3219 1.54 0.88 2.68 0.13
Teaching Hospital 11936 9156 2.16 1.23 3.79 0.007
doi:10.1371/journal.pone.0047474.t003
Table 4. Significant risk factors for death in pediatric patients with convulsive status epilepticus following multivariate analysis.
Predictor Odds Ratio P Value Lower 95% Upper 95%
African American Race 0.36 0.009 0.17 0.78
December Admission 3.38 ,0.001 2.01 5.67
Admission Source
Emergency Room 1.00 - - -
Birth 1.34 0.279 0.79 2.29
Outside Hospital 1.58 0.073 0.96 2.60
Outside Facility 2.05 0.159 0.75 5.56
Comorbidities
Sepsis 10.14 ,0.001 4.02 25.57
Hypoglycemia 5.79 0.004 1.75 19.16
Near Drowning 43.17 0.001 4.37 426.82
Hemorrhagic Shock 17.83 0.001 6.47 49.12
Structural Brain Lesion 7.01 ,0.001 3.07 15.98
Massive Aspiration 9.11 0.008 1.77 47.01
Postoperative Sepsis with Liver Failure 14.44 ,0.001 4.98 41.86
Procedures
Transfusion 8.25 ,0.001 4.32 15.78
Mechanical Ventilation 9.03 ,0.001 5.59 14.60
.72 hours
doi:10.1371/journal.pone.0047474.t004
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Author, Year and Study Design Follow up Mortality rate Predictors/Risk Factors
Aicardi et al, 1970 [12]
Retrospective
Discharge
Unclear
4.2% (10/239)
11% (27/239)
Prolonged SE, cerebral disease
Chevrie et al, 1978 [19]
Prospective
,4 year f/u 21/334 in 1
st year Symptomatic seizures, age ,6 months
Dunn et al, 1988 [13]
Prospective
Discharge 8.24% (8/97) Severe pre-existing brain damage,
meningitis and encephalopathy
Maytal et al, 1989 [41]
Retrospective with prospective follow-up
13.2 months 7.2% (7/97) Prolonged SE
DeLorenzo et al, 1992 [14]
Retrospective and prospective
7 years 2.3% of children
25% in adults
Tumor, hematological disease, anoxia,
metabolic and congenital malformations
Scholtes et al, 1996 [42]
Retrospective
Discharge 11.5% (13/112) Anoxia, presence of .1 complication,
insufficient therapy, prolonged duration
(.8 hrs)
Logroscino et al, 1997 [6]
Retrospective
19 years 21% (38/184) ,1 year age, acute illness
Barnard et al, 1999 [22]
Retrospective
Discharge
53 months
9.6% (5/52)
15.4% (8/52)
Brain tumors, metabolic disorder, multi-
organ failure
Mah et al, 1999 [10]
Retrospective
5 years 2% SE group
1.5% in NSE group
Drug overdose, sepsis, disseminated
tuberculosis, congenital heart disease
Waterhouse et al, 1999 [34]
Prospective
- 17.8% (5.2 in pediatric
and 24%)
CNS infection, hypoxia, drug withdrawal,
continuous SE
Berg et al, 2001 [9]
Prospective
4 years 1.6% (10/613) Neurodegenerative conditions, coexisting
medical conditions
Callenbach et al, 2001 [24]
Retrospective
4 years 1.9% (9/472) Respiratory insufficiency, RSV infection,
aspiration, brain herniation
Kim et al, 2001 [43]
Case series
4 years 43.5% (10/23) Acute symptomatic etiology, especially
anoxia
Sahin et al, 2001 [4]
Retrospective
8 years 31.8% (7/22) Remote symptomatic and progressive
encephalopathy
Tabarki et al, 2001 [44]
Retrospective
7 years 15.8% (22/139) Acute symptomatic seizure, progressive
encephalopathy
Logroscino G et al 2002 [39]
Retrospective
Unclear 43% Prolonged SE (.24 hr), acute
symptomatic etiology, myoclonic SE
Ogutu et al, 2002 [45]
Pharmacokinetics and clinical effects measurements
Discharge 13.1% (5/38) Intracranial hypertension, intractable
convulsions
Sillanpa ¨a ¨ et al, 2002 [2]
Prospective
Long follow up 16% (24/150) Remote symptomatic cause, young
patient (,6 yrs), partial seizures, history
of febrile seizure
Singhi et al, 2002 [46]
Prospective
Discharge 25% (10/40) Early intubation and ventilation,
meningoencephalitis, acute
hyponatremia, hepatic encephalopathy
Wu et al, 2002 [3]
Retrospective
Discharge 1.9% (55/2885) Female sex, older age (.75)
KarasalIhoGlu et al, 2003 [47]
Retrospective
1 month 7.2% (6/83) Polypharmacy, discontinuation of AEDs,
neuromotor retardation, generalized
background abnormality on EEG
Berg et al, 2004 [30]
Prospective
Unclear 2.1% (13/613) Neurodegenerative disorder 6 epileptic
encephalopathy, prolonged SE
Chin et al, 2004 [26]
Retrospective
Discharge 5.1% (5/98) Younger age, intubation, CNS infection,
hyponatremia, hypoxia, sepsis, subdural
hematoma
Asadi-Pooya et al, 2005 [48]
Retrospective
Discharge 10.4% (14/135) Prolonged febrile seizure, CNS infection,
metabolic/AED withdrawal, symptomatic
epilepsy, prolonged stay
Brevoord et al, 2005 [25]
Retrospective
Discharge 5.7% (7/205) Near drowning episode, pneumococcal
meningitis, cardiac failure, brainstem
tumor, hemorrhagic shock, metabolic
defect
Gulati et al, 2005 [8]
Retrospective
Discharge 30% (9/30) Prolonged SE (.45 min), septic shock
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noted in prospective [29] and retrospective [26] pediatric studies.
Human immunodeficiency virus-associated encephalitis was iden-
tified as a cause of SE in one previous pediatric study [4]. In our
present data sample, we found intracranial infections, such as viral
encephalitis and infectious encephalopathy, to be associated with
mortality. These factors did not emerge as independent risk factors
for death in multivariate analysis in this series.
Other comorbidities. Brain herniation was associated with
an increased risk of death. Transtentorial herniation was identified
as a long-term cause of death in a prior retrospective pediatric
study [24]. Similarly, subdural hematoma, noted as a cause of
death in a previous pediatric case series [33], was associated with
mortality in our study. However, these factors were not found to
be a significant risk factor for death in multivariate analysis. Unlike
prior studies [34], patients with status following drug withdrawal
did not have a higher mortality rate in this dataset.
Procedures
Blood Transfusion. We identified blood transfusion as a
factor for fatalities. This additional risk is probably not a result of
the transfusion in itself but is likely a marker for the poor clinical
condition of certain patients who subsequently require greater
intervention. While this finding was not corroborated by prior
research, studies investigating patients with related markers of
disease severity, such as those investigating ICU patients, have
similarly high death rates [8,25].
Mechanical Ventilation. The need for ventilatory support in
convulsive SE may arise from poor respiratory drive resulting from
seizure complications or in the context of pharmacological coma
induction. The risk of death in mechanical ventilation may be
related to the risk of aspiration and impaired mucociliary
clearance, leading to pneumonia [35]. Additionally, mechanical
ventilation is also associated with complications such as pneumo-
thorax and ventilator-associated lung injury. We confirmed
mechanical ventilation as an independent risk factor for death in
SE. Mechanical ventilation was associated with death in a
prospective study that included adolescents and children [36].
Similar findings were noted in a randomized control trial
comparing antiepileptic medications in the treatment of SE [37].
Risk factors assessment in SE. We investigated diagnostic
entities due to their known association with high risk of mortality.
The KID mentions all diagnoses encountered during a hospital
admission irrespective of the cause-effect relationship between SE
and associated diagnoses. Entities such as near drowning,
hemorrhagic shock, structural brain lesion, and hypoglycemia
(likely causes of SE), as well as sepsis, prolonged mechanical
ventilation, and transfusion (likely resulting from SE or its
Table 5. Cont.
Author, Year and Study Design Follow up Mortality rate Predictors/Risk Factors
Kang et al, 2005 [23]
Retrospective
Unclear 3% Higher mortality in acute symptomatic SE
versus remote symptomatic SE
Maegaki et al, 2005 [49]
Retrospective
Discharge 3.8% (9/241) Prolonged SE (.2 hr), moderate-severe
asthma
Ozdemir et al, 2005 [11]
Retrospective
Discharge 19% (5/27) Acute symptomatic SE, progressive
encephalopathy, underlying disease
Ahmad et al, 2006 [50]
Randomized controlled trial
Discharge 17.5% (N=160) Progressive infection, cerebral malaria,
febrile convulsions, acute bacterial
meningitis, metabolic derangements
Chen et al, 2006 [51]
Population based study
Discharge 3.1% (7/226) Febrile illness, acute bacterial meningitis,
progressive neurological disorders,
intermittent SE.
Morrison et al, 2006 [33]
Retrospective
Discharge 18% (3/17) Subdural hematoma, birth asphyxia, post-
cardiac arrest
Hayashi et al, 2007 [52]
Retrospective
Discharge 2.1% (10/479) Encephalitis, cerebrovascular disease
Muchochi et al, 2007 [53]
Non-randomized controlled
Discharge 11.54% (3/26) Pre-existing cerebral malaria, convulsions
Mpimbaza et al, 2008 [54]
Randomized controlled trial
Discharge 6% (20/330) Malaria, severe malnutrition,
immunosuppression, pneumonia
Sadarangani et al, 2008 [29]
Retrospective
Discharge Confirmed convulsive
SE: 19% (11/58)
Probable convulsive
SE: 11% (13/120)
Acute bacterial meningitis, age ,1 year,
hypoglycemia, focal onset seizures
Siddiqui et al, 2008 [55]
Retrospective
Discharge 12% (15/125) Acute intracranial infections, age ,5
years, prolonged SE (5.9365.76 hours)
Lin et al, 2009 [56]
Retrospective
Stay in ICU
Unclear
8.51% (12/141)
9.2% (13/141)
Febrile illness
Mei Li et al, 2009 [36]
Retrospective
1 month 15.8% (32/203) Mechanical ventilation, complications, SE
duration after admission, hyponatremia,
recurrent SE
Molinero et al, 2009 [27]
Prospective
Discharge 13% (6/47) Infectious cause, cerebrovascular
accident, long seizure duration
AED – antiepileptic drug; SE – status epilepticus; CNS – central nervous system; ICU – intensive care unit; RSV – respiratory syncytial virus.
doi:10.1371/journal.pone.0047474.t005
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Awareness of these risks may thus promote more improved
targeted management towards correcting these conditions.
Challenges. The findings of this study need to be interpreted
in the setting of data acquisition and subsequent analysis.
Misclassification of seizures and comorbidities in the ICD-9
coding system is a potential source of error, as it is with all large
databases studies. Multiple criteria exist to diagnose SE. While the
Working Group of SE of the Epilepsy Foundation of America
defines SE as a seizure of at least 30 minutes duration or multiple
seizures without full recovery of consciousness in between [1],
other investigators advocate a cutoff time as short as five minutes
[38]. Individual physicians may not use the same operational
definitions, leading to variations in case reporting. The KID
dataset lacks information on the timing of procedures, such as
blood transfusion and intubation, which may also be important
variables in determining the risk of death in SE. Patients who
suffer from SE are noted to have an increased risk of dying that
extends to weeks, and possibly years, after discharge [39]. This
information is unavailable in the KID dataset. Because there are
no unique patient identifiers in the KID dataset, it was not possible
to account for multiple episodes of SE in the same patient. While
neonates were included in this study, there is a lack of consensus
on the definition of SE in these patients. This study was unable to
investigate certain variables, such as seizure duration, and some
etiologies, such as cerebrovascular accidents and malaria, which
have been identified as important risk factors in other studies due
to few numbers of these cases.
Conclusion
Convulsive SE is a rare but serious condition and results in
approximately 0.1% of all pediatric inpatient hospital admissions.
It is fatal in approximately 1% of cases. The rarity of this condition
makes it a difficult subject to study. The use of large nationwide
databases, such as the KID dataset permits identification of factors
associated with increased mortality.
The findings from this study suggest new directions for research.
Research should be done to determine which interventions may
lead to improved outcomes. More data are needed to ascertain risk
factors for long-term mortality in pediatric SE. Parallel research
using large groups of adults should be done to establish risk factors
for poor outcomes in this group. This may also help to identify risk
factors that overlap between pediatric and adult populations.
Prospective multicenter studies evaluating children presenting in
SE may assist in better determination of risk factors for death and
identify those interventions which best promote patient survival.
Our results may also carry implications for improvement of
patient care. It is likely that in-hospital mortality of SE is largely a
function of the underlying cause of the SE, while other factors may
also have an impact on outcome. Some of these risk factors may be
ameliorated with specific therapy. Mild induced hypothermia, for
example, may be beneficial in patients with near-drowning
episodes [40]. Early identification and treatment of some of these
aggravating factors may not only prevent immediate mortality, but
it may also reduce long-term complications and limit neurological
dysfunction. Beyond these implications, the development of
treatment paradigms may also help reduce variability in care
and outcomes and thereby decrease hospital costs. This research
may lead the development of warning algorithms which may in
turn promote early interventions that reduce ICU admissions,
other medical complications, and even death. Identification of risk
factors is thus an important first step towards providing improved
care when caring for pediatric patients with SE.
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